AI systems generate and modify regulated data faster than audit trails were designed to track; FDA is now scrutinizing exactly what those trails capture
Determining when an AI tool becomes a validated system requires a risk-based, function-level assessment; FDA is now enforcing it through warning letters
A structured approach to a crowded, high-stakes purchase: defining requirements, weighing the criteria that matter, assessing vendors, and getting implementation right